Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Janux Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Janux Therapeutics Inc
Rating: 1.18766675
Author: Trendlyne DVM scores

about

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

14.81 -0.33 (-2.18%)

New 52W Low in past week

1.6M

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

16.7 / 100

Technically Bearish

30.8 / 100

1Yr Price target upside is 329%

17 analysts

Janux Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Janux Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (...

New 52W Low in past week

SWOT Analysis

Janux Therapeutics Inc Live Price Chart